News and Trends 2 Feb 2023 Recurv Pharma receives funding for cancer therapy development …our cancer program, RP-001. Taxanes have been a cornerstone of cancer treatment for decades, but they can come with significant side effects, and treated cancers frequently recur. We are looking… February 2, 2023 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 9 May 2023 Gilead boosts oncology pipeline with XinThera acquisition …(HRD) tumors with BRCA-mutations such as breast, ovarian, prostate, and pancreatic cancers, but their use is limited due to hematological toxicities. PARP1 selective inhibitors have the potential to mitigate the… May 9, 2023 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 27 Jan 2023 Onxeo to study prostate cancer drug …with relapsed platinum sensitive ovarian cancer already under treatment with a PARP inhibitor. The study is sponsored by Gustave Roussy Cancer Campus, Grand Paris, led by Patricia Pautier and supported… January 27, 2023 - 4 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 21 Aug 2017 First-in-Human Trial will test a New Cancer Therapy from Switzerland Cellestia Biotech will start human trials with CB-103, an anticancer drug targeting the Notch signaling pathway, known for its ubiquity in cancer. Cellestia Biotech, based in Basel, has announced it… August 21, 2017 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
In Depth 10 Jan 2023 Innovative biomaterials are revolutionizing tissue regeneration …it for very special cases.” These applications include coatings for medical implants such as those used in breast implants. A very thin layer of silk protein on the outside of… January 10, 2023 - 14 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email
In Depth 3 Sep 2025 How are biotechs tackling malaria? …with lumefantrine, which provides sustained antimalarial activity, improves the efficacy. Coartem Baby is designed to dissolve in liquids, including breast milk, and has a sweet cherry flavor, making it easier… September 3, 2025 - 13 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 26 Feb 2018 AstraZeneca Collaborates With Swedish Biotech To Speed Up Drug Development …and breast cancer. While AstraZeneca is undoubtedly an important partner for Pelago, they are not short of noteworthy collaborators. Pfizer, WuXi AppTec and Sygnature Discovery have all signed up to… February 26, 2018 - 2 minutesmins - By Alexander Burik Share WhatsApp Twitter Linkedin Email
News and Trends 28 Jun 2017 A Peek into the Icelandic Company using Fish Skin to Heal Wounds …a high omega-3 content, which has anti-inflammatory properties. The material, approved not only for wounds, but also for burns, hernia repair, diabetic foot, breast reconstruction and the repair of spinal… June 28, 2017 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 7 Feb 2017 Cannabinoid Drug Prolongs the Life of Brain Tumor Patients in Phase II Trials …of cannabinoids in tumor growth and progression in multiple forms of cancer. From lung to breast, pancreatic, melanoma ovarian, gastric, renal, prostate and bladder cancer. GW’s Sativex (nabiximols) was the… February 7, 2017 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email